A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2017
At a glance
- Drugs Testosterone cipionate (Primary) ; Testosterone enanthate (Primary) ; Enzalutamide
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms TRANSFORMER
- 07 Jun 2017 Biomarkers information updated
- 29 May 2015 Trial design presented at 51st Annual Meeting of the American Society of Clinical Oncology.
- 10 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClkinicalTrials.gov record.